International guidelines are developed with a rigorous, evidence-based approach to provide consistency in care and evaluate the balance of treatment risk and harms.1 However, there are limitations to guidelines as they cannot address every patient's individual needs. Listen to Dr. Heather Reich give her expert view on the utilization of guidelines to improve treatment strategies for patients with IgA nephropathy.
References: 1. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. Rovin, Brad H. et al. Kidney International, Volume 100, Issue 4, 753 – 779. https://doi.org/10.1016/j.kint.2021.05.015